Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_assertion type Assertion NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_head.
- NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_assertion description "[dc-CISH is a promising alternative to FISH in HER2 testing, and the single-institute incidence of HER2 amplification in breast cancer in Taiwan is 21.2%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_provenance.
- NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_assertion evidence source_evidence_literature NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_provenance.
- NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_assertion SIO_000772 22092410 NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_provenance.
- NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_assertion wasDerivedFrom befree-2016 NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_provenance.
- NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_assertion wasGeneratedBy ECO_0000203 NP939434.RAxZ4PEXlBMZB2k5rmaU4fDojkd4U2ySdzAd_Yf9ROGaU130_provenance.